University of Rome “G.Marconi”, 
 Via Plinio, 44-00193 Rome
Italy						                            
                            
						
 Review Article
												New Winning Strategies for Vitiligo: The Low Dose Cytokines Therapy Approach 						
Author(s): Torello  Lotti, Tania  Rivkina and Miroslava  KadurinaTorello  Lotti, Tania  Rivkina and Miroslava  Kadurina             
						
												
				 Vitiligo is a dermatologic pigmentary disorder triggered by melanocytes’ loss and sustained by a deep immune imbalance which induce chronic inflammation and excessive oxidative stress phenomena at skin level. Current therapies are mainly symptomatic and designed in order to inhibit the inflammatory mediators at vitiligo patches level. To restore the correct immune balance between Th1/Th17 and Th2/Treg response and concomitantly rebalancing the inflammatory response represents an innovative and effective approach for Vitiligo treatment; Low Dose Medicine theories and the availability of specific low dose SKA interleukins, antibodies and growth factors allows researchers and clinicians to act simultaneously against all the main etiologic causes of vitiligo and makes possible to design new therapeutic approaches for vitiligo.
.. Read More»
				  
												DOI:
												 10.4172/2376-0427.1000229 
																	  
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report